Author(s):
GK Sudhakar, Vasudev Pai, Arvind Pai.
Email(s):
Email ID Not Available
DOI:
Not Available
Address:
G K Sudhakar1*, Vasudev Pai2, Arvind Pai1
1Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal-576104, Karnataka, INDIA.
2Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal-576104, Karnataka, INDIA.
*Corresponding Author
Published In:
Volume - 5,
Issue - 6,
Year - 2013
ABSTRACT:
Breast cancer is the most common forms of female cancers. External factors like obesity, late pregnancies or no pregnancies, use of tobacco and alcohol have increased the risk of cancer in women. Targeted therapy is new type of cancer treatment that uses drugs precisely and attaches cancer cells with minimum damage to normal cells. It is multimodality cancer treatment regimens that include chemotherapy, surgery and radiation therapy. It has limited toxicity and target cancer cells which carry specific receptors (estrogen receptor). Third generation Aromatase Inhibitors (AIs) like Exemestane are emerging as potential therapeutic agents for breast cancer.
Cite this article:
GK Sudhakar, Vasudev Pai, Arvind Pai.
An overview on current Strategies in Breast Cancer Therapy. Research J. Pharmacology and Pharmacodynamics. 2013; 5(6): 353-355 .
Cite(Electronic):
GK Sudhakar, Vasudev Pai, Arvind Pai.
An overview on current Strategies in Breast Cancer Therapy. Research J. Pharmacology and Pharmacodynamics. 2013; 5(6): 353-355 . Available on: https://rjppd.org/AbstractView.aspx?PID=2013-5-6-18